LPX-TI641 is a novel, orally bioavailable, potent small-molecule immunomodulator that restores immune tolerance by targeting multiple pathways implicated in autoimmune diseases.Topline Phase 1 ...
there are notable differences While they both fall under the "arthritis" umbrella and share certain similarities, these diseases have significant differences. Osteoarthritis is caused by the breakdown ...
In recognising this UK Sport’s approach to funding reflects that journey and works on the basis of an athlete pathway with three clear and distinct levels that make up the World Class Pathway. The two ...